ArticleEBioMedicine2020

Molecular correlates of sensitivity to PARP inhibition beyond homologous recombination deficiency in pre-clinical models of colorectal cancer point to wild-type TP53 activity.

Jørgen Smeby et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.